The link with human cognitive impairment is still hypothetical, and the use of GnRH therapy as a treatment for dementia would depend on whether GnRH neurons are adversely affected by aging or other pathological drivers of disease, such as neuritic plaques in AD. This evidence concerns the gene GNRH1 and Cognitive impairment.